"BLK-Max Super Speciality Hospital has a unique combination of the best in class technology, put to use by the best names in the professional circles to ensure world-class health care to all patients. Spread on five acres of land, with a capacity of 650 beds, BLK-Max Super Speciality Hospital is one of the largest tertiary care private hospitals in the country, BLK-Max has consistently ranked amongst the Top 10 Multi Super Specialty Hospitals in Delhi NCR. The outpatient services are spread on two floors with 80 consultation rooms. All ambulatory services have been designed with intent to create dedicated aides for all specialities, with their interventional services in close vicinity."

During the past decade, BLK Super Specialty Hospital conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "BLK Super Specialty Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Bayer" with 1 trials sponsored, "BrainQ Technologies Ltd." with 1 trials sponsored and "Fresenius Kabi" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "BLK Super Specialty Hospital" #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator, "Janssen Research & Development, LLC" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "BLK Super Specialty Hospital" are "Breast Cancer" (2 trials), "Influenza A" (2 trials), "Acute Stroke" (1 trials), "Caloric Deficit" (1 trials) and "Malnutrition" (1 trials). Many other conditions were trialed in "BLK Super Specialty Hospital" in a lesser frequency.

Most popular intervention types in "BLK Super Specialty Hospital" are "Drug" (6 trials), "Other" (2 trials), "Biological" (1 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Abemaciclib" (2 trials), "Pimodivir 600 mg" (2 trials), "SOC Treatment" (2 trials) and "Anastrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "BLK Super Specialty Hospital" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "BLK Super Specialty Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in BLK Super Specialty Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in BLK Super Specialty Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".